There is a record of it somewhere. A printed summary from a VA visit, a photo you took of a label, a line typed into your phone at two in the morning. Sertraline through most of a winter. Bupropion stacked on in March. Venlafaxine after that, because the first pair left you muted rather than better. Each attempt spent a season of your life, and each one wound down the same way, with a shrug, a dose adjustment, and one more slip of paper.
Read the record as data, not as a grade. When three prescriptions in a row come up short, the usual reason is that what they were aimed at was not the whole of what is going on.
Where the usual sequence stops paying off
Prescribing for depression is organized as a staircase. Begin one drug, hold it six to eight weeks, judge it, push the dose, then trade it out or stack something on top. Nothing about that design is careless, and most prescribers have sound reasons for walking it in order. It does burn calendar, though, and every landing tends to give back less than the one below it. STAR*D, the biggest real world examination of that staircase, found remission growing less likely at each rung past the first (Rush et al., Am J Psychiatry, 2006).
Veterans who end up on a page like this one are usually standing on the third or fourth step already. That is not strange. It means the staircase was never designed to carry anyone this far.
What a service record adds that a fifteen minute med check never asks
A short medication appointment exists to tune a prescription. Taking a life history is a different job, and it rarely gets done, so the same blanks stay blank while the scripts keep rotating.
Sleep, described honestly. Not whether you sleep, but what the night actually consists of: hours logged, times awake, whether you finish it on the couch angled toward the door. Apnea nobody has tested for and insomnia you quit mentioning both hold a low mood in place, and both are ordinary after years of shift rotations, field time, and a back that never got a chance to settle.
Pain. Background pain steers mood by itself, and the drugs aimed at it tangle with most of the antidepressant list.
Drinking, counted accurately. Nobody wants that conversation in a ten minute slot with someone they met four minutes ago. It still changes what a medication can do.
Hits to the head, including every one you never reported. A blast you judged far enough away at the time. A rollover. A fall in training where you stood up, finished the day, and never walked to the aid station. Wrestling or football before you ever signed anything. Clinical literature treats a history of head trauma as one risk marker for depression that ordinary prescribing does not move, which is exactly why the history belongs in writing. On its own it is not a reason to choose any particular treatment, and anyone who turns that association into a reason to sell you something has outrun what the research actually says.
Grief, and the moral weight of what you did or watched. Part of what you are carrying was never a chemistry question, and no tablet was ever the right tool for it. Saying so out loud does not cancel the medical half of the work. It keeps the two halves from being mistaken for one another.
What is actually available after two or three tries
Two options carry federal approval for depression that has already resisted a pair of adequate drug trials. One is Spravato: esketamine in a nasal spray, given inside a clinic authorized to hand it out under a restricted distribution program, with a watching period after each dose and a daily tablet continuing underneath it. The other is transcranial magnetic stimulation, a run of brief outpatient visits that aim magnetic pulses at one mapped location on the head. No sedation. No needles.
Ketamine by infusion is used for depression as well, in clinics, off label. Off label means the drug carries approval for other uses and is being prescribed here on a clinician's judgment. That is not automatically a warning sign, and it is still a fair thing to make someone say plainly.
None of this is a small decision, and none of it arrives with assurances. What it offers is a road other than the one that has already failed to get you anywhere, more than once.
Ask sooner than feels permitted. No rule says you have to work through every item on the formulary first. If you would rather know what a first visit involves before you commit to scheduling one, Brain Recovery Centers posts its intake page for veterans and first responders, laying out how it asks about deployments, blast exposure, and the trials already behind you.
Before your next appointment
Put the list on paper. Drug, dose, how long you stayed with it, one line on why it ended. A prescriber reads a timeline far faster than they can rebuild one from memory, and an adequate trial is defined by dose and duration, not by whether a bottle got filled.
Ask whether you meet the definition of treatment-resistant depression, and ask what happens if the next medication also does nothing. Someone who has already thought about step four will answer. Someone who has not will tell you plenty by pausing.
If the VA is your care, ask whether community care covers the option you are asking about, and ask who files that request.
Distance is not the obstacle here. Clinics working specifically on treatment-resistant depression sit in St. Peters, O'Fallon, Ballwin, and Chesterfield, and across the rest of St. Louis County.
One last thing. If your thoughts have turned toward not being here, that cannot wait on a calendar. The 988 line runs day and night, by call or by text, and pressing 1 puts you with people whose whole job is service members and veterans. An emergency department will take you in without an appointment. The slower conversation about next steps keeps until tomorrow.